A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
Clinical trial NCT00175825 · COMPLETED
Trial details
- NCT number
- NCT00175825
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-07
- Primary completion
- 2006-06-29
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.